Caption Management, LLC Bicycle Therapeutics PLC Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$20.02 - $31.37 $520,520 - $815,620	26,000 New	26,000 $553,000
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $492,268 - $1.79 Million	-38,013 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$40.12 - $59.5 $1.53 Million - $2.26 Million	38,013 New	38,013 $1.67 Million

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.